Scinovex
article Open AccessTop 10% cited

CTLA-4 and PD-1 Receptors Inhibit T-Cell Activation by Distinct Mechanisms

Molecular and Cellular Biology · 2005 · Vol. 25(21) · pp. 9543–9553
Richard V. ParryJens M. ChemnitzKenneth A. FrauwirthAnthony R. LanfrancoInbal BraunsteinSumire KobayashiPeter S. LinsleyCraig B. ThompsonJames L. Riley

Abstract

CTLA-4 and PD-1 are receptors that negatively regulate T-cell activation. Ligation of both CTLA-4 and PD-1 blocked CD3/CD28-mediated upregulation of glucose metabolism and Akt activity, but each accomplished this regulation using separate mechanisms. CTLA-4-mediated inhibition of Akt phosphorylation is sensitive to okadaic acid, providing direct evidence that PP2A plays a prominent role in mediating CTLA-4 suppression of T-cell activation. In contrast, PD-1 signaling inhibits Akt phosphorylation by preventing CD28-mediated activation of phosphatidylinositol 3-kinase (PI3K). The ability of PD-1 to suppress PI3K/AKT activation was dependent upon the immunoreceptor tyrosine-based switch motif located in its cytoplasmic tail, adding further importance to this domain in mediating PD-1 signal transduction. Lastly, PD-1 ligation is more effective in suppressing CD3/CD28-induced changes in the T-cell transcriptional profile, suggesting that differential regulation of PI3K activation by PD-1 and CTLA-4 ligation results in distinct cellular phenotypes. Together, these data suggest that CTLA-4 and PD-1 inhibit T-cell activation through distinct and potentially synergistic mechanisms.

Immune Cell Function and InteractionT-cell and B-cell ImmunologyImmune cells in cancerBiologyPhosphorylationCell biologyCD28Protein kinase BPI3K/AKT/mTOR pathwaySignal transductionT-cell receptorT cellImmunology

MeSH terms

Phosphoinositide-3 Kinase InhibitorsAntigens, DifferentiationAntigens, SurfaceEnzyme ActivationGene Expression RegulationHumansLymphocyte ActivationPhosphatidylinositolsPhosphoprotein PhosphatasesPhosphorylationT-LymphocytesSignal TransductionAntigens, CDCD3 ComplexCD28 Antigens

Funding

  • National Institute of Allergy and Infectious Diseases
Citations
1,889
FWCI
6.81
field-weighted impact
References
73
Percentile
98%
vs. same field & year
Citations per year
Cited by
PD-1 and Its Ligands in Tolerance and Immunity
Annual Review of Immunology · 2008 · 5,272 citations
Role of the PD-1 Pathway in the Immune Response
American Journal of Transplantation · 2012 · 427 citations
PD‐1/PD‐L1 immune checkpoint: Potential target for cancer therapy
Journal of Cellular Physiology · 2018 · 506 citations
CD8 T Cell Exhaustion During Chronic Viral Infection and Cancer
Annual Review of Immunology · 2019 · 1,900 citations
PD‐1 signaling in primary T cells
Immunological Reviews · 2009 · 762 citations
Citation Network

How this paper connects to the literature. Drag to explore, click any node to open that paper.

CTLA-4 and PD-1 Receptors Inhibit T-Cell Activation by Distinct Mechanisms · Scinovex